The Global Health Body Issues Alert Over Severe Shortage of Weight-Loss Jabs
Under 10% of people who could benefit from weight-loss injections like Wegovy have access to them, warns the global health agency as it publishes its initial advice on the therapies.
Considering in excess of 1,000,000,000 people worldwide currently classified as obese, it is advocating for increased and just availability to GLP-1 medication.
According to projections, over two billion could be obese by 2030 without intervention.
"Our new guidelines recognises that obesity is a chronic disease that can be managed with holistic and ongoing support," said the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and logistical bottlenecks are key obstacles to universal availability to the jabs that can aid individuals in losing significant weight, says the agency.
Weight-Loss Drug Supply Crisis
Even under the present most optimistic case, the manufacturing of such drugs could only cover approximately 100 million people – fewer than 10% of the global need, per the health organization.
The guideline encourages nations and manufacturers to widen access, by strategies like patent sharing.
Exclusive production rights on a key compound – the primary component of Novo Nordisk's Wegovy – is due to expire in multiple countries in 2026.
The Way Obesity Jabs Function
These medications mimick a body's own hormone to reduce digestion speed, suppress the appetite and enhance the sense of being full so individuals consume fewer calories.
Individuals typically begin shedding pounds within a few weeks of commencing the weekly injections.
Research suggests people may see weight return a year later of halting the treatment, as their normal appetite resume.
Being above a healthy weight elevates your likelihood for experiencing health problems, including diabetes, heart disease, brain attack, and some cancers.
Excess weight impacts individuals in all nations and was linked to millions of deaths worldwide in 2024, according to the WHO.
